The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'

Janssen's Erleada shown to reduce PSA progression by 94% in nmCRPC patients.....           South Korea?s GC Pharma establishes vaccine development firm Curevo.....           FDA approves AstraZeneca?s Lokelma to treat hyperkalemia in adults.....           Roche's two phase 3 studies show Hemlibra reduces bleeding in hemophilia patients.....           Biopharmaceutical firm Accent Therapeutics launches with $40m financing.....           FiercePharmaAsia?WuXi?s and Sinobioway?s new sites, Takeda?s financials and R&D plan.....           Novartis and Amgen secure FDA approval for migraine drug.....           Pfizer?s Lyrica meets primary endpoint in phase 3 pediatric epilepsy trial.....           Ipsen?s Cabometyx secures approval in Europe for first-line kidney cancer.....           WuXi and Sinobioway add capacity to nab expected wave of Chinese biologics.....           Amgen's Aimovig won its first-in-class migraine nod. Will payers step up to the $6,900 price?.....           Allergan's besieged Restasis patents get smacked again, this time in retailer antitrust suit.....           Vermont thumbs its nose at Trump with a new law blessing Canadian drug imports.....           FDA declines to approve Evolus' DWP-450 for glabellar lines.....           IDMC recommends to expand Tiziana?s phase 2a trial of Milciclib.....           OptiBiotix Health signs manufacturing and supply deal in India with Akums.....           HiFiBiO Therapeutics raises $37.5m in Series B funding.....           Price check at FDA: Trump pushes for pharma ads with dollar signs.....           AbbVie bows to pressure to keep cheaper Imbruvica formula on the market.....           Valeant's ex-CEO jumped into Philidor deal even after being warned of potential collusion, jurors told.....           FDA approves Pfizer?s epoetin alfa biosimilar Retacrit to treat anemia.....           Novartis completes $8.7bn acquisition of AveXis.....           Surface Pharmaceuticals secures $20m funding from Flying L Partners.....           In early test, Inovio's HIV vaccine delivered immune responses that lasted at least 6 months.....           Feds join lawsuits claiming Insys used strip club visits, super-doses and more to boost Subsys sales.....           Azar threatens drugmakers with Trump's temper if they hike prices for no reason.....           In early test, Inovio's HIV vaccine delivered immune responses that lasted at least 6 months.....           Lilly to acquire AurKa Pharma in $575m deal.....           Aquestive settles Suboxone drug patent infringement case with Par Pharmaceuticals.....           Zymeworks, Daiichi Sankyo expand immuno-oncology partnership.....           China's Sinobioway Biomedicine says it will invest nearly $500M in massive biologics site.....           AstraZeneca?s COPD drug Fasenra fails to meet primary endpoint in phase III trial.....           Pharma and healthcare boost digital ad spend on the way to $4.5B in 2021.....           China's Sinobioway Biomedicine says it will invest nearly $500M on massive biologics site.....           Merck's experimental Ebola shot gets set to fight deadly new outbreak in Congo.....           FDA expands approval of Novartis? Gilenya to treat MS in pediatric patients.....           RXi Pharmaceuticals enters into research collaboration with Iovance Biotherapeutics.....           Hemogenyx collaborates with undisclosed global pharmaceutical firm on CDX antibodies development.....           AstraZeneca?s COPD drug Fasenra fails to meet primary endpoint in Galathea phase III trial.....           Skepticism on the wane? Reputation study says U.S. patient groups give props to pharma.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
Latest news

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

APS events overview

The APS has developed an exciting and informative programme for our events in 2018.

We are re-running the Developability Workshop and Regulatory Essentials training events which have proved enormously popular when run before.

In March, we have the first one of our collaborative meetings, 'Emerging technologies in therapeutic oligonucleotides', hosted by MedImmune, followed by 'APS Current Regulatory trends and updates in parenteral drug product development' that will be informative and interactive describing the current regulatory requirements, especially focusing on recent changes in guidelines, as well as covering topical issues, trends and developments in the wider field of parenteral products.

Don’t forget to make a note of APS@FIP, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference.

Please take a look at our programme, with event summaries, below:

Emerging technologies in therapeutic oligonucleotides
13 March 2018 - MedImmune, Cambridge
MedImmune, AstraZeneca and GE Healthcare Life Sciences, in partnership with GSK, Roche, University of Oxford, BioMax and Academy of Pharmaceutical Sciences are pleased to invite you to their sixth oligonucleotide networking event.
To learn more and to register, click here

APS Current Regulatory trends and updates in parenteral drug product development
20 - 21 March 2018 - Burleigh Court, Loughborough University
This residential course is aimed at pharmaceutical scientists and regulatory affairs professionals involved in the development, manufacture, control or registration of parenteral products. Speakers will include key industry and MHRA experts.
To learn more and to register, click here

APS Industrial Insights
26 - 27 March 2018 - Pfizer / Mylan at Discovery Park, Sandwich
EarlyBird deadline extended to midnight on Monday 5 March... register now!
An event for undergraduate and postgraduate students interested in exploring opportunities in the Pharmaceutical Industry, through a series of talks by pharmaceutical scientists working within the industry as well as a tour of the Pfizer Research and Development facilities.
To learn more and to register, click here

Accelerating paediatric formulation development
Presentation of output from SPaeDD-UK Project

28 March 2018 - Friends House, London
The Smart Paediatric Drug Development (SPaeDD) initiative co-funded by Innovate UK (the UK’s Innovation Agency) is a cross company and academic centre initiative to accelerate paediatric formulation development. The collaboration has now reached the end of its funding period and this meeting will present the final outputs from the project work streams. Each of these has produced outputs which will no doubt significantly assist the way in which medicines are developed and tested for children.
To learn more and to register, click here

APS Developability Workshop
10 - 11 April 2018 - Granta Park, Cambridge
Learn from a pharmaceutics and biopharmaceutics perspective what is required to assess a molecule in discovery and its suitability for ‘candidate selection’; determine how ‘developable’ it is with associated risk, time and cost implications; and what is needed to progress it through pre-clinical studies and into Phase 1 and 2a clinical studies to achieve Proof of Concept.
To learn more and to register, click here

APS Regulatory Essentials II
22—23 May 2018 - Burleigh Court, Loughborough University
This is a residential course aimed at pharmaceutical scientists and regulatory/quality professionals in originator and generics’ companies who will benefit from gaining a better appreciation of key elements in the development and registration of oral dosage forms.
To learn more and to register, click here

7 September 2018 - Hilton Hotel, Glasgow
Linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference, which will take place in the city from the 2 - 6 September 2018. The theme of this conference in 2018 is 'The Science of Differentiated Medicines'.
To learn more and to register, click here

Developability for Biologicals
Inhaled Workshop
Basic Biopharmaceutics workshop
Nanomedicine drug delivery: Opportunities and Challenges
OrBiTo (Innovative Tools for Oral Biopharmaceutics) Conference


Reflections on APS PharmSci 2017 Conference

Date: 5 - 7 September 2017
Location: De Havilland Campus, University of Hertfordshire, Hatfield
Conference Chair: Professor Abdul Basit (University College London)
Theme: Pharmaceutical Science without Borders

A very successful 3-day conference provided an excellent interactive face to face forum for exchange of knowledge and sharing learnings and experiences in many aspects of the pharmaceutical sciences. With 80+ inspiring speakers and over 390 delegates joined together from academia, the Pharmaceutical Industry, and service companies. During the sessions, there was a steady flow of discussion which continued into the breaks and around the exhibition stands and posters.

Young pharmaceutical scientists had their first opportunity to present either a poster or podium presentation (or indeed both!) which is a major strength of APS PharmSci.


Read more, as Linda Hakes (Retiring APS Chair) and Mark McAllister (APS Chair) talk about their experiences at this year’s PharmSci.

Follow us
Upcoming Events
APS Regulatory Essentials II
22 - 23 May 2018
APS Nanomedicines for the Delivery of Biologics
18 July 2018
7 September 2018
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.


The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351
Fax: 0116 274 7365

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.